Overview

Phase 2b Controlled Study of Dosing Techniques - Part B

Status:
ACTIVE_NOT_RECRUITING
Trial end date:
2025-12-31
Target enrollment:
Participant gender:
Summary
Double-masked, dose-response of two concentrations of IVW-1001
Phase:
PHASE2
Details
Lead Sponsor:
IVIEW Therapeutics Inc.